These dates stem from a 60-day grace period for 503A (from February 21 to April 22, 2025) and 90 days for 503B (to May 22, 2025), designed to avoid disrupting patient treatment
Your provider will tailor the supplement plan to your specific needs and goals
Many people start treatment expecting weight loss to feel easier, then become frustrated when results slow down, stop or do not match expectations
Youre a good candidate for this treatment if you: Patients with a personal or family history of medullary thyroid carcinoma or MEN2, active pancreatitis, or allergy to the medication are generally NOT candidates
However it's definitely not advisable to try and take both a pill and the jab at the same time
This affected the plotted log fold-change values but does not alter the interpretation of the results, which were discussed only in general terms, nor does it impact the manuscripts conclusions